BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15309803)

  • 1. Origin, antigenic specificity and regulation of autoantibodies targeting Ro/La RNP.
    Routsias JG; Tzioufas AG
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S63-5. PubMed ID: 15309803
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor.
    Yount WJ; Cohen P; Eisenberg RA
    Monogr Allergy; 1988; 23():41-56. PubMed ID: 2968502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.
    Bini P; Chu JL; Okolo C; Elkon K
    J Clin Invest; 1990 Feb; 85(2):325-33. PubMed ID: 1688881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune response and target autoantigens in Sjogren's syndrome.
    Routsias JG; Tzioufas AG
    Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A B cell apotope of Ro 60 in systemic lupus erythematosus.
    Reed JH; Jackson MW; Gordon TP
    Arthritis Rheum; 2008 Apr; 58(4):1125-9. PubMed ID: 18383373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjögren's syndrome.
    Reed JH; Dudek NL; Osborne SE; Kaufman KM; Jackson MW; Purcell AW; Gordon TP
    Arthritis Rheum; 2010 May; 62(5):1448-56. PubMed ID: 20131295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
    Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
    J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren's syndrome using luciferase immunoprecipitation systems (LIPS).
    Volchenkov R; Jonsson R; Appel S
    Scand J Rheumatol; 2012 Aug; 41(4):314-5. PubMed ID: 22804348
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
    Harley JB; Scofield RH; Reichlin M
    Rheum Dis Clin North Am; 1992 May; 18(2):337-58. PubMed ID: 1626073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate T cell epitopes of the human La/SSB autoantigen.
    Davies ML; Taylor EJ; Gordon C; Young SP; Welsh K; Bunce M; Wordsworth BP; Davidson B; Bowman SJ
    Arthritis Rheum; 2002 Jan; 46(1):209-14. PubMed ID: 11817592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of Ro (SS-A) and La (SS-B) antibodies in lupus erythematosus.
    Provost TT
    Semin Dermatol; 1988 Jun; 7(2):130-9. PubMed ID: 3153434
    [No Abstract]   [Full Text] [Related]  

  • 15. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.
    Yiannaki EE; Tzioufas AG; Bachmann M; Hantoumi J; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Clin Exp Immunol; 1998 Apr; 112(1):152-8. PubMed ID: 9566804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitopic targets for autoantibodies in systemic lupus erythematosus and Sjögren's syndrome.
    Chan EK; Tan EM
    Curr Opin Rheumatol; 1989 Oct; 1(3):376-81. PubMed ID: 2484307
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
    Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
    Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus.
    Elkon KB; Culhane L
    J Immunol; 1984 May; 132(5):2350-6. PubMed ID: 6715882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated and nonphosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics.
    Coudevylle N; Rokas D; Sakarellos-Daitsiotis M; Krikorian D; Panou-Pomonis E; Sakarellos C; Boussard G; Cung MT
    Biopolymers; 2006; 84(4):368-82. PubMed ID: 16453388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.